NO172541C - Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater

Info

Publication number: NO172541C
Authority: NO; Norway
Prior art keywords: preparation; hydrogen; pyridoindol; derivatives; procedure
Prior art date: 1988-09-27

Application number

NO893820A

Other languages

English (en)

Norwegian (no)

Other versions

NO172541B (no

NO893820L (no

NO893820D0 (no

Inventor

Masayuki Kato

Kiyotaka Ito

Hisashi Takasugi

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-09-27

Filing date

1989-09-26

Publication date

1993-08-04

1988-09-27 Priority claimed from GB888822646A external-priority patent/GB8822646D0/en

1989-02-10 Priority claimed from GB898903044A external-priority patent/GB8903044D0/en

1989-09-26 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1989-09-26 Publication of NO893820D0 publication Critical patent/NO893820D0/no

1990-03-28 Publication of NO893820L publication Critical patent/NO893820L/no

1993-04-26 Publication of NO172541B publication Critical patent/NO172541B/no

1993-08-04 Publication of NO172541C publication Critical patent/NO172541C/no

Links

IVCGJOSPVGENCT-UHFFFAOYSA-N 1h-pyrrolo[2,3-f]quinoline Chemical class N1=CC=CC2=C(NC=C3)C3=CC=C21 IVCGJOSPVGENCT-UHFFFAOYSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 4
229910052739 hydrogen Inorganic materials 0.000 abstract 4
239000001257 hydrogen Substances 0.000 abstract 4
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 4
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000004423 acyloxy group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000002883 imidazolyl group Chemical group 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Pyridine Compounds (AREA)
Cephalosporin Compounds (AREA)

NO893820A 1988-09-27 1989-09-26 Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater NO172541C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB888822646A GB8822646D0 (en)	1988-09-27	1988-09-27	Pyridoindole derivatives & processes for preparation thereof
GB898903044A GB8903044D0 (en)	1989-02-10	1989-02-10	Pyridoindole derivatives and processes for preparation thereof

Publications (4)

Publication Number	Publication Date
NO893820D0 NO893820D0 (no)	1989-09-26
NO893820L NO893820L (no)	1990-03-28
NO172541B NO172541B (no)	1993-04-26
NO172541C true NO172541C (no)	1993-08-04

Family

ID=26294446

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO893820A NO172541C (no)	1988-09-27	1989-09-26	Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater

Country Status (20)

Country	Link
US (1)	US5141945A (de)
EP (1)	EP0361317B1 (de)
JP (1)	JPH02117675A (de)
KR (1)	KR0143999B1 (de)
CN (1)	CN1024552C (de)
AT (1)	ATE120743T1 (de)
AU (1)	AU627221B2 (de)
CA (1)	CA1338474C (de)
DE (1)	DE68922053T2 (de)
DK (1)	DK170168B1 (de)
ES (1)	ES2070154T3 (de)
FI (1)	FI92200C (de)
GR (1)	GR3015713T3 (de)
HK (1)	HK102096A (de)
HU (2)	HU206209B (de)
IE (1)	IE67350B1 (de)
IL (1)	IL91756A (de)
NO (1)	NO172541C (de)
PT (1)	PT91795B (de)
RU (1)	RU2001915C1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5173493A (en) *	1988-09-27	1992-12-22	Fujisawa Pharmaceutical Company, Ltd.	Pyridoindole derivatives and processes for preparation thereof
US5290785A (en) *	1988-09-27	1994-03-01	Fujisawa Pharmaceutical Co., Ltd.	Therapeutic agent for ischemic diseases
GB9214184D0 (en) *	1992-07-03	1992-08-12	Smithkline Beecham Plc	Pharmaceuticals
CN1118990A (zh) *	1993-03-08	1996-03-20	藤泽药品工业株式会社	治疗或预防脑血管疾病药物
DE69525354T2 (de) *	1994-09-19	2002-08-14	Fujisawa Pharmaceutical Co., Ltd.	Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
US6013653A (en) *	1995-09-22	2000-01-11	Fujisawa Pharmaceuticals Co., Ltd.	Processes for producing pyridoindole derivatives
FR2869316B1 (fr) *	2004-04-21	2006-06-02	Sanofi Synthelabo	Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
US20200375957A1 (en)	2017-04-24	2020-12-03	Chase Therapeutics Corporation	Compositions and method for treating depression
CN116003407B (zh) *	2022-12-27	2025-04-01	株洲千金药业股份有限公司	一种大规模生产唑吡坦的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR920003064B1 (ko) *	1984-01-25	1992-04-13	글락소 그룹 리미티드	헤테로시클릭 화합물의 제조방법
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
GB8518743D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Heterocyclic compounds
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones

1989
- 1989-09-14 AU AU41406/89A patent/AU627221B2/en not_active Ceased
- 1989-09-19 IE IE299989A patent/IE67350B1/en not_active IP Right Cessation
- 1989-09-20 US US07/409,744 patent/US5141945A/en not_active Expired - Fee Related
- 1989-09-21 DE DE68922053T patent/DE68922053T2/de not_active Expired - Fee Related
- 1989-09-21 AT AT89117498T patent/ATE120743T1/de not_active IP Right Cessation
- 1989-09-21 ES ES89117498T patent/ES2070154T3/es not_active Expired - Lifetime
- 1989-09-21 EP EP89117498A patent/EP0361317B1/de not_active Expired - Lifetime
- 1989-09-24 IL IL91756A patent/IL91756A/xx not_active IP Right Cessation
- 1989-09-25 PT PT91795A patent/PT91795B/pt not_active IP Right Cessation
- 1989-09-25 FI FI894506A patent/FI92200C/fi not_active IP Right Cessation
- 1989-09-25 CA CA000612855A patent/CA1338474C/en not_active Expired - Fee Related
- 1989-09-26 CN CN89107692A patent/CN1024552C/zh not_active Expired - Fee Related
- 1989-09-26 DK DK474089A patent/DK170168B1/da not_active IP Right Cessation
- 1989-09-26 NO NO893820A patent/NO172541C/no unknown
- 1989-09-26 RU SU894742106A patent/RU2001915C1/ru active
- 1989-09-26 KR KR1019890013798A patent/KR0143999B1/ko not_active Expired - Fee Related
- 1989-09-26 HU HU895038A patent/HU206209B/hu not_active IP Right Cessation
- 1989-09-27 JP JP1252986A patent/JPH02117675A/ja active Granted
1995
- 1995-04-06 GR GR950400770T patent/GR3015713T3/el unknown
- 1995-06-22 HU HU95P/P00372P patent/HU211139A9/hu unknown
1996
- 1996-06-13 HK HK102096A patent/HK102096A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
IE892999L (en)	1990-03-27
IL91756A (en)	1993-07-08
HK102096A (en)	1996-06-21
DK474089D0 (da)	1989-09-26
DE68922053T2 (de)	1995-08-10
IE67350B1 (en)	1996-03-20
JPH02117675A (ja)	1990-05-02
EP0361317A3 (de)	1991-07-24
PT91795A (pt)	1990-03-30
US5141945A (en)	1992-08-25
AU4140689A (en)	1990-04-05
FI92200B (fi)	1994-06-30
ATE120743T1 (de)	1995-04-15
CA1338474C (en)	1996-07-23
HUT51623A (en)	1990-05-28
FI92200C (fi)	1994-10-10
DK170168B1 (da)	1995-06-06
NO172541B (no)	1993-04-26
EP0361317A2 (de)	1990-04-04
GR3015713T3 (en)	1995-07-31
IL91756A0 (en)	1990-06-10
PT91795B (pt)	1995-05-31
FI894506L (fi)	1990-03-28
HU211139A9 (en)	1995-10-30
AU627221B2 (en)	1992-08-20
JPH054392B2 (de)	1993-01-19
CN1041594A (zh)	1990-04-25
CN1024552C (zh)	1994-05-18
NO893820L (no)	1990-03-28
DE68922053D1 (de)	1995-05-11
DK474089A (da)	1990-03-28
HU206209B (en)	1992-09-28
RU2001915C1 (ru)	1993-10-30
KR0143999B1 (ko)	1998-07-15
KR900004733A (ko)	1990-04-12
NO893820D0 (no)	1989-09-26
EP0361317B1 (de)	1995-04-05
ES2070154T3 (es)	1995-06-01
FI894506A0 (fi)	1989-09-25

Publication	Publication Date	Title
NO890723D0 (no)	1989-02-21	Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
NO913750D0 (no)	1991-09-24	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO173139C (no)	1993-11-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
AU624405B2 (en)	1992-06-11	Heterocyclic bisphosphonic acid derivatives
NO172541C (no)	1993-08-04	Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO881835D0 (no)	1988-04-27	Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
FR2618436B1 (fr)	1989-10-27	Derives de piperidine, leur preparation et leur application en therapeutique
NO173278C (no)	1993-12-01	Analogifremgangsm}te for fremstilling av terapeutisk aktive 5-androsten-17-on-derivater
NO894325L (no)	1990-05-02	Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
ES2087173T3 (es)	1996-07-16	Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.
EP0420086A3 (en)	1991-11-06	Pyrimidoindole derivatives and processes for preparation thereof
DK168284A (da)	1984-10-01	Troponderivater
EP0452809A3 (en)	1992-04-15	A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives